SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-025892
Filing Date
2021-05-13
Accepted
2021-05-13 06:01:34
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_inmedpharma.htm 10-Q 520652
2 CERTIFICATION f10q0321ex31-1_inmed.htm EX-31.1 15121
3 CERTIFICATION f10q0321ex31-2_inmed.htm EX-31.2 14127
4 CERTIFICATION f10q0321ex32-1_inmed.htm EX-32.1 4261
5 CERTIFICATION f10q0321ex32-2_inmed.htm EX-32.2 4214
6 GRAPHIC image_001.jpg GRAPHIC 13138
  Complete submission text file 0001213900-21-025892.txt   3001642

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE inm-20210331.xml EX-101.INS 426908
8 XBRL SCHEMA FILE inm-20210331.xsd EX-101.SCH 49551
9 XBRL CALCULATION FILE inm-20210331_cal.xml EX-101.CAL 25184
10 XBRL DEFINITION FILE inm-20210331_def.xml EX-101.DEF 169062
11 XBRL LABEL FILE inm-20210331_lab.xml EX-101.LAB 353501
12 XBRL PRESENTATION FILE inm-20210331_pre.xml EX-101.PRE 183948
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 21917023
SIC: 2834 Pharmaceutical Preparations